Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Understanding the links between cardiovascular disease and Parkinson's disease
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4614051
Author(s) Potashkin, Judy; Huang, Xuemei; Becker, Claudia; Chen, Honglei; Foltynie, Thomas; Marras, Connie
Author(s) at UniBasel Becker, Claudia
Year 2020
Title Understanding the links between cardiovascular disease and Parkinson's disease
Journal Movement disorders : official journal of the Movement Disorder Society
Volume 35
Number 1
Pages / Article-Number 55-74
Keywords Parkinson's disease; cardiovascular; pathogenesis; risk factors
Mesh terms Cardiovascular Diseases, diagnosis, epidemiology, therapy; Comorbidity; Diabetes Mellitus, Type 2, complications, diagnosis, therapy; Disease Progression; Humans; Parkinson Disease, diagnosis, epidemiology, therapy; Risk Factors
Abstract Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research. © 2019 International Parkinson and Movement Disorder Society.
Publisher Wiley-Liss
ISSN/ISBN 0885-3185 ; 1531-8257
edoc-URL https://edoc.unibas.ch/81276/
Full Text on edoc No
Digital Object Identifier DOI 10.1002/mds.27836
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31483535
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.380 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024